Lai TYY - Search Results

1

Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG, Lai TYY, Ikuno Y, Cohen SY, Gaudric A, Jonas JB. Ohno-Matsui K, et al. Among authors: lai tyy. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5. doi: 10.1167/iovs.62.5.5. Invest Ophthalmol Vis Sci. 2021. PMID: 33909033 Free PMC article. Review.

2

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Chan WM, Lai TY, Wong AL, Liu DT, Lam DS. Chan WM, et al. Br J Ophthalmol. 2007 Feb;91(2):174-9. doi: 10.1136/bjo.2006.103606. Epub 2006 Sep 20. Br J Ophthalmol. 2007. PMID: 16987898 Free PMC article. Clinical Trial.

3

Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia.

Cheung BT, Lai TY, Yuen CY, Lai WW, Tsang CW, Lam DS. Cheung BT, et al. Br J Ophthalmol. 2007 Jun;91(6):719-21. doi: 10.1136/bjo.2006.111526. Epub 2007 Jan 17. Br J Ophthalmol. 2007. PMID: 17229801 Free PMC article.

4

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.

Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP. Lam DS, et al. Ophthalmology. 2007 Dec;114(12):2162-7. doi: 10.1016/j.ophtha.2007.02.006. Epub 2007 Apr 25. Ophthalmology. 2007. PMID: 17459479 Clinical Trial.

5

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS. Chan WM, et al. Ophthalmology. 2007 Dec;114(12):2190-6. doi: 10.1016/j.ophtha.2007.03.043. Epub 2007 Jun 28. Ophthalmology. 2007. PMID: 17599414 Clinical Trial.

6

Genotype phenotype analysis of Bietti's crystalline dystrophy in patients with CYP4V2 mutations.

Lai TY, Ng TK, Tam PO, Yam GH, Ngai JW, Chan WM, Liu DT, Lam DS, Pang CP. Lai TY, et al. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5212-20. doi: 10.1167/iovs.07-0660. Invest Ophthalmol Vis Sci. 2007. PMID: 17962476

7

Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Chan WM, et al. Ophthalmology. 2008 Oct;115(10):1756-65. doi: 10.1016/j.ophtha.2008.04.014. Epub 2008 Jun 5. Ophthalmology. 2008. PMID: 18538401 Clinical Trial.

8

Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia.

Lai TY, Chan WM, Liu DT, Lam DS. Lai TY, et al. Retina. 2009 Jun;29(6):750-6. doi: 10.1097/IAE.0b013e31819ed6bd. Retina. 2009. PMID: 19357555

9

Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus.

Liang XY, Lai TY, Liu DT, Fan AH, Chen LJ, Tam PO, Chiang SW, Ng TK, Lam DS, Pang CP. Liang XY, et al. Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3175-82. doi: 10.1167/iovs.11-8135. Invest Ophthalmol Vis Sci. 2012. PMID: 22491416

10

Choroidal neovascularization in pathological myopia.

Neelam K, Cheung CM, Ohno-Matsui K, Lai TY, Wong TY. Neelam K, et al. Prog Retin Eye Res. 2012 Sep;31(5):495-525. doi: 10.1016/j.preteyeres.2012.04.001. Epub 2012 Apr 28. Prog Retin Eye Res. 2012. PMID: 22569156 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters